What this means
This is a planned study that has not started enrolling people yet. It will check whether the injection is safe and well tolerated, but it has no results.
Plain-English summary written by an AI model from the registry listing.
- Status
- Opening soon
- Who can join
- Ages 18–75
- Where
- Not listed
The science
- Registered title
- Preliminary Evaluation of the Safety and Tolerability of SPOT-mRNA01 Subcutaneously Administered in Healthy Subjects
- Trial ID
- NCT06567119 ↗
- Phase
- PHASE 1
- Study type
- interventional
- Conditions
- Skin Aging
- What is tested
- SPOT-mRNA01, Placebo
- Sponsor
- SIPO Biotechnology Co. Ltd.
- Ages
- 18 Years to 75 Years
- Dates
- First posted Aug 22, 2024 · updated Apr 23, 2026
Registry summary
This is a first-in-human, randomized, double-blind, placebo-controlled clinical study to evaluate the Safety and Tolerability of SPOT-mRNA01 injection in healthy adult volunteers.